Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Generalized hyperpigmentation with daunorubicin chemotherapy.

George Kroumpouzos1, Robin Travers, Anne Allan

  • 1Department of Dermatology, Boston Medical Center, Boston University School of Medicine, MA, USA. kroumpouzos.george@boston.va.gov

Journal of the American Academy of Dermatology
|January 25, 2002
PubMed
Summary

Daunorubicin chemotherapy can cause skin darkening. A case study revealed generalized hyperpigmentation in sun-protected areas, differing from typical sun-exposed skin reactions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Topical Melatonin in Aesthetic Dermatology: From Cutaneous Melatoninergic Biology to Photoprotection, and Skin Rejuvenation.

Clinics in dermatology·2026
Same author

Tanorexia: The psychodermatology of compulsive tanning.

Clinics in dermatology·2026
Same author

Anti-TNFa As a Treatment Option for Synchronous Folliculitis Keloidalis and Hidradenitis Suppurativa.

International journal of dermatology·2026
Same author

Future directions: Generative AI, foundation models, and what lies ahead.

Presse medicale (Paris, France : 1983)·2026
Same author

Sleep quality in patients with mycosis fungoides and its relationship with dermatology-specific quality of life.

Clinics in dermatology·2026
Same author

Persona non grata: Identifying patients unsuitable for aesthetic dermatologic procedures.

Clinics in dermatology·2026

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Daunorubicin is an anthracycline chemotherapy agent used in treating various cancers.
  • Previous reports indicate daunorubicin can induce hyperpigmentation, primarily on sun-exposed skin and nails.

Observation:

  • A case of an African American man treated with daunorubicin is presented.
  • This patient developed an unusual pattern of generalized hyperpigmentation.
  • The hyperpigmentation affected sun-protected skin areas, appearing two weeks post-treatment.

Findings:

  • Histopathological examination of the affected skin revealed increased melanin granules throughout all epidermal layers.
  • This suggests a significant alteration in melanogenesis or melanosome distribution.

Related Experiment Videos

Implications:

  • The findings broaden the understanding of daunorubicin-induced dermatological side effects.
  • This case highlights the potential for atypical and widespread hyperpigmentation beyond sun-exposed areas.
  • Further research into the precise mechanisms of daunorubicin's effect on melanocytes is warranted.